Skip to content

Psychedelic Use and Behavioral Addictions.

Trey Brasher, David Rosen, Marcello Spinella

Journal of Psychoactive Drugs March 15, 2025 DOI: 10.1080/02791072.2025.2474244 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional survey Pilot study Peer reviewed
Sample size 1,107
Population Community sample of adults
Topics Addiction
Keywords Psychedelics Behavioral addiction Naturalistic Self-report survey
Citations 1
Key findings Psychedelic use uniquely predicted lower behavioral addiction scores, while major stimulant, alcohol, and nicotine vaping use predicted higher scores.

Abstract

Recent clinical trials on classic psychedelics for depression and anxiety have raised questions about their potential to treat other psychiatric conditions. Evidence from pre-clinical and clinical research suggests psychedelics may help with substance use disorders, with ongoing registered trials. Behavioral addictions, sharing features with substance addictions, may also respond to psychedelic treatment. This study examined self-reported symptoms of problem gambling, sexual addiction, compulsive buying, and eating disorders in a community sample (N = 1107), alongside measures of well-being (self-transcendence, personal growth, depression/anxiety, etc.), and use of psychedelics and other psychoactive drugs. Significant positive correlations emerged among well-being measures and among behavioral addiction symptoms, with inverse correlations between well-being and behavioral addictions. Psychedelic users reported greater well-being and lower behavioral addiction symptoms, even after controlling for demographics and other drug use. Principal components analysis showed that behavioral addictions formed a single factor, which was combined into a composite score. Multiple regression analyses revealed that major stimulant, alcohol, and nicotine vaping use predicted higher behavioral addiction scores, while psychedelic use uniquely predicted lower scores. These findings suggest psychedelics may aid in treating behavioral addictions. A controlled pilot study or clinical trial is warranted to explore this therapeutic potential further.

Comparable studies

Other cross-sectional and survey studies on addiction, most cited first.

Study Year Design Participants
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Online survey respondents 2020 Cross-sectional survey
The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations International users of novel psychoactive substances recruited via bluelight.org 2016 Cross-sectional online survey n = 619
User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire 2010 Cross-sectional survey n = 600
Psychological and neuropsychological assessment of regular hoasca users. Regular hoasca users from a U.S. branch of União do Vegetal and matched non-user controls 2016 Cross-sectional study n = 57
Client and counselor attitudes toward the use of medications for treatment of opioid dependence. Counselors and clients from outpatient, methadone, and residential drug treatment programs 2007 Cross-sectional survey n = 1,459

Citations in the library

Explore topics